56 related articles for article (PubMed ID: 22236334)
1. ALK status in a primary lung tumour and metachronous metastases.
Salido M; Pijuan L; Galván AB; Gimeno J; Cañadas I; Rodriguez-Rivera M; Rojo F; Albanell J; Solé F; Arriola E
Histopathology; 2012 Apr; 60(5):843-5. PubMed ID: 22236334
[No Abstract] [Full Text] [Related]
2. Immunohistochemical screening and fluorescence in situ hybridization confirmation of ALK translocation in lung adenocarcinoma and its clinicopathological significance: a single-center large-scale investigation of Chinese patients.
Wang WY; Liang DN; Yao WQ; Wu WL; Li JN; Chen M; Liao DY; Zhang M; Li GD
Hum Pathol; 2014 Jul; 45(7):1414-22. PubMed ID: 24775606
[TBL] [Abstract][Full Text] [Related]
3. Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases.
Kim H; Xu X; Yoo SB; Sun PL; Jin Y; Paik JH; Choe G; Jheon S; Lee CT; Chung JH
Histopathology; 2013 Jan; 62(2):305-14. PubMed ID: 23020707
[TBL] [Abstract][Full Text] [Related]
4. Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
Yamamoto M; Takeuchi K; Shimoji M; Maniwa T; Isaka M; Nakagawa K; Ohde Y; Kondo H; Nakajima T
Cancer Sci; 2012 Feb; 103(2):390-2. PubMed ID: 22296236
[TBL] [Abstract][Full Text] [Related]
5. Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
Yoshida A; Tsuta K; Watanabe S; Sekine I; Fukayama M; Tsuda H; Furuta K; Shibata T
Lung Cancer; 2011 Jun; 72(3):309-15. PubMed ID: 21036415
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
[TBL] [Abstract][Full Text] [Related]
7. Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.
Jokoji R; Yamasaki T; Minami S; Komuta K; Sakamaki Y; Takeuchi K; Tsujimoto M
J Clin Pathol; 2010 Dec; 63(12):1066-70. PubMed ID: 20935334
[TBL] [Abstract][Full Text] [Related]
8. ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript.
Wang WY; Gu L; Liu WP; Li GD; Liu HJ; Ma ZG
Pathol Res Pract; 2011 Sep; 207(9):587-91. PubMed ID: 21855232
[TBL] [Abstract][Full Text] [Related]
9. Targeting anaplastic lymphoma kinase in lung cancer.
Shaw AT; Solomon B
Clin Cancer Res; 2011 Apr; 17(8):2081-6. PubMed ID: 21288922
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ALK gene status in primary lung adenocarcinoma and matched metastases.
Rossi A; Galetta D; Bottiglieri L; Stufano V; Barberis M
J Thorac Oncol; 2011 Jun; 6(6):1146. PubMed ID: 21623283
[No Abstract] [Full Text] [Related]
11. [Detection of ALK positive pulmonary adenocarcinoma using immunostaining].
Ikeda S; Takabe K; Inagaki M; Funakoshi N; Suzuki K
Rinsho Byori; 2010 Jun; 58(6):565-70. PubMed ID: 20662267
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
[TBL] [Abstract][Full Text] [Related]
13. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
[TBL] [Abstract][Full Text] [Related]
14. Case records of the Massachusetts General Hospital. Case 21-2011. A 31-year-old man with ALK-positive adenocarcinoma of the lung.
Shaw AT; Forcione DG; Digumarthy SR; Iafrate AJ
N Engl J Med; 2011 Jul; 365(2):158-67. PubMed ID: 21751909
[No Abstract] [Full Text] [Related]
15. Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.
Tomizawa K; Ito S; Suda K; Fukui T; Usami N; Hatooka S; Kuwano H; Yatabe Y; Mitsudomi T
Lung Cancer; 2013 Apr; 80(1):99-101. PubMed ID: 23279872
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
[TBL] [Abstract][Full Text] [Related]
17. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
Shinmura K; Kageyama S; Tao H; Bunai T; Suzuki M; Kamo T; Takamochi K; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
[TBL] [Abstract][Full Text] [Related]
18. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
19. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
[TBL] [Abstract][Full Text] [Related]
20. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.
Lamant L; Gascoyne RD; Duplantier MM; Armstrong F; Raghab A; Chhanabhai M; Rajcan-Separovic E; Raghab J; Delsol G; Espinos E
Genes Chromosomes Cancer; 2003 Aug; 37(4):427-32. PubMed ID: 12800156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
